Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-21

Clinical Trial Update: A Study of SCTB35 in Patients with Systemic Lupus Erythematosus [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for SCTB35 in patients with systemic lupus erythematosus, currently recruiting in Phase 1/Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SCTB35

Snippet

Sponsor: Sinocelltech Ltd. | Conditions: System Lupus Erythematosus | Phase 1, Phase 2 | Status: RECRUITING